Fmr LLC Fulgent Genetics, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Fmr LLC holds 3,409 shares of FLGT stock, worth $77,554. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,409

Previous 1,324 157.48%

Holding current value

$77,554

Previous $28,000 135.71%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$19.09 - $22.57 $39,802 - $47,058	2,085 Added 157.48%	3,409 $66,000
Q1 2024 May 13, 2024	SELL	$21.55 - $29.29 $1,443 - $1,962	-67 Reduced 4.82%	1,324 $28,000
Q4 2023 Feb 13, 2024	BUY	$23.64 - $30.27 $6,666 - $8,536	282 Added 25.43%	1,391 $40,000
Q3 2023 Nov 13, 2023	SELL	$26.74 - $40.81 $2,246 - $3,428	-84 Reduced 7.04%	1,109 $29,000
Q2 2023 Aug 11, 2023	SELL	$28.52 - $40.7 $19,136 - $27,309	-671 Reduced 36.0%	1,193 $44,000
Q1 2023 May 11, 2023	BUY	$29.39 - $36.27 $24,246 - $29,922	825 Added 79.4%	1,864 $58,000
Q4 2022 Feb 13, 2023	SELL	$29.23 - $40.28 $787,339 - $1.08 Million	-26,936 Reduced 96.29%	1,039 $30,000
Q3 2022 Nov 10, 2022	BUY	$37.92 - $63.74 $205,109 - $344,769	5,409 Added 23.97%	27,975 $1.07 Million
Q2 2022 Aug 12, 2022	BUY	$47.98 - $62.75 $289,847 - $379,072	6,041 Added 36.56%	22,566 $1.23 Million
Q1 2022 May 13, 2022	BUY	$49.85 - $96.11 $811,109 - $1.56 Million	16,271 Added 6405.91%	16,525 $1.03 Million
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $927 - $1,260	-12 Reduced 4.51%	254 $25,000
Q3 2021 Nov 15, 2021	SELL	$74.87 - $110.87 $3,668 - $5,432	-49 Reduced 15.56%	266 $23,000
Q2 2021 Aug 13, 2021	BUY	$66.8 - $100.45 $21,042 - $31,641	315 New	315 $29,000

Others Institutions Holding FLGT

# of Institutions

195

Shares Held

15.3M

Call Options Held

1.07M

Put Options Held

27.9K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $689M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account